COMMUNIQUÉS West-GlobeNewswire

OpGen Announces Date of First Quarter 2018 Financial Results Conference Call
01/05/2018
GAITHERSBURG, Md., May 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of the U.S. financial [...]
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
01/05/2018
Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved [...]
Capital Senior Living Corporation Reports First Quarter 2018 Results
01/05/2018
DALLAS, May 01, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
TESARO Announces Participation in Two Investor Conferences
01/05/2018
WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]
Prothena to Report First Quarter 2018 Financial Results on May 8
01/05/2018
DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and [...]
resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference
01/05/2018
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
K2M Group Holdings, Inc. Reports First Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook
01/05/2018
LEESBURG, Va., May 01, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO ) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
Pernix Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 10
01/05/2018
MORRISTOWN, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today that the Company will report financial results for the first [...]
Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2018 Financial Results and Recent Highlights
01/05/2018
SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Tuesday, May 8 th , 2018 at 4:30 p.m. Eastern Time to [...]
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
01/05/2018
MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ) today announced it will report first quarter financial results and provide a corporate update on May 8, 2018. The [...]
GenMark Diagnostics Reports First Quarter 2018 Results
01/05/2018
CARLSBAD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and [...]
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
01/05/2018
Mechelen, Belgium and Planegg/Munich, Germany; 1 May 2018; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that the first [...]
Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference
01/05/2018
MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Mersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference
01/05/2018
CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/05/2018
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Teladoc Announces First Quarter 2018 Results
01/05/2018
1Q 2018 Revenue of $89.6 million, growth of 109% Total Paid Membership of 20.8 million, growth of 41% 1Q 2018 Total Visits of 606,000, growth of 57% PURCHASE, NY, May 01, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate Update
01/05/2018
BURNABY, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2018 financial [...]
Retrophin Reports First Quarter 2018 Financial Results
01/05/2018
Company obtains FDA and EMA feedback on pathway to NDA and MAA filing for sparsentan in IgA nephropathy; single Phase 3 trial expected to initiate in the fourth quarter of 2018 Pivotal Phase 3 DUPLEX Study of sparsentan [...]

Pages